This study is currently not recruiting participants.

Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

Not Recruiting
18 years - 100 years
All
Phase N/A

Brief description of study.

This phase II/III trial studies how well lenalidomide works and compares it to observation in treating patients with asymptomatic high-risk smoldering multiple myeloma.

Detailed description of study

This randomized phase II/III trial studies how well lenalidomide works and compares it to observation in treating patients with asymptomatic high-risk asymptomatic (smoldering) multiple myeloma.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Multiple Myeloma
  • Age: 18 years - 100 years
  • Gender: All
Updated on 30 May 2014. Study ID: E3A06

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team